Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation
Digital Biomarkers · 09.08.2023 · 74-91
DOI: 10.1159/000531054 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digital Biomarkers, online erschienen am 09.08.2023. Verfasst von Bohdana Ratitch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Statistics and Data Insights, Bayer Inc., Mississauga, ON, Canada. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Assessment of reliability is one of the key components of the validation process designed to demonstrate that a novel clinical measure assessed by a digital health technology tool is fit-for-purpose in clinical research, care, and decision-making. Reliability assessment contributes to characterization of the signal-to-noise ratio and measurement error and is the first indicator of potential usefulness of the proposed clinical measure. Summary: Methodologies for reliability analyses are scattered across literature on validation of PROs, wet biomarkers, etc., yet are equally useful for digital clinical measures. We review a general modeling framework and statistical metrics typically used for reliability assessments as part of the clinical validation. We also present methods for the assessment of agreement and measurement error, alongside modified approaches for categorical measures. We illustrate the discussed techniques using physical activity data from a wearable device with an accelerometer sensor collected in clinical trial participants. Key Messages: This paper provides statisticians and data scientists, involved in development and validation of novel digital clinical measures, an overview of the statistical methodologies and analytical tools for reliability assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Statistics and Data Insights, Bayer Inc., Mississauga, ON, Canada.
- Medical Affairs Statistics, Bayer plc, Reading, UK.
- Statistics and Data Insights, Bayer Corporation, Whippany, NJ, USA.
- Statistics and Data Insights, Bayer AG, Wuppertal, Germany.
- Clinical Development and Operations, Bayer AG, Berlin, Germany.
Zitieren
APA
Ratitch, B., Trigg, A., Majumder, M., Vlajnic, V., Rethemeier, N., & Nkulikiyinka, R. (2023). Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation. Digital Biomarkers, 74-91. https://doi.org/10.1159/000531054
Vancouver
Ratitch B, Trigg A, Majumder M, Vlajnic V, Rethemeier N, Nkulikiyinka R. Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation. Digital Biomarkers. 2023:74-91. doi:10.1159/000531054
BibTeX
@article{Ratitch2023,
author = {Ratitch, Bohdana and Trigg, Andrew and Majumder, Madhurima and Vlajnic, Vanja and Rethemeier, Nicole and Nkulikiyinka, Richard},
title = {Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation},
journal = {Digital Biomarkers},
year = {2023},
pages = {74--91},
doi = {10.1159/000531054}
}
EUVIMED